Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
DOD Toxic Exposures, Investigator-Initiated Research Award
The FY22 TERP IIRA is intended to support studies that will make an important contribution toward research and/or patient care for a disease or condition related to toxic exposures.
Research projects may focus on any phase of research from basic laboratory research through translational research,
including preclinical studies in animal models and human subjects, as well as correlative studies associated with an existing clinical trial.
New Approach Methodologies may also be used.Impact:
The application should explicitly state how the proposed research will have a significant impact on toxic exposure research and/or patient care with the intent to transition outcomes into clinical practice for Service Members, Veterans, and/or the American public who have been, or could potentially be, impacted by toxic exposures.
State both the short- and long-term impacts and how the proposed research will ultimately lead to new treatments/therapeutics, diagnostic assays, or prevention strategies to improve the quality of life for those that have been impacted by, or are likely to encounter, toxic substances.Applications should clearly demonstrate the project’s potential near-term and long-term outcome(s)/product(s) (intellectual knowledge and/or tangible materiel) and how they will impact a critical problem or question in the field of research and/or patient care in at least one of the FY22 TERP Program Goals and at least one of the FY22 TERP Topic Areas addressed.Preliminary data are required.
The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data.
Applications must include relevant preliminary data that support the rationale for the proposed study.
These data may be unpublished or from published literature.Proposed research may be related to diseases, conditions, or symptoms supported by other CDMRP programs; however, TERP applications must be relevant to toxic exposures and be responsive to the FY22 TERP Program Goals and Topic Areas.
Research projects may focus on any phase of research from basic laboratory research through translational research,
including preclinical studies in animal models and human subjects, as well as correlative studies associated with an existing clinical trial.
New Approach Methodologies may also be used.Impact:
The application should explicitly state how the proposed research will have a significant impact on toxic exposure research and/or patient care with the intent to transition outcomes into clinical practice for Service Members, Veterans, and/or the American public who have been, or could potentially be, impacted by toxic exposures.
State both the short- and long-term impacts and how the proposed research will ultimately lead to new treatments/therapeutics, diagnostic assays, or prevention strategies to improve the quality of life for those that have been impacted by, or are likely to encounter, toxic substances.Applications should clearly demonstrate the project’s potential near-term and long-term outcome(s)/product(s) (intellectual knowledge and/or tangible materiel) and how they will impact a critical problem or question in the field of research and/or patient care in at least one of the FY22 TERP Program Goals and at least one of the FY22 TERP Topic Areas addressed.Preliminary data are required.
The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data.
Applications must include relevant preliminary data that support the rationale for the proposed study.
These data may be unpublished or from published literature.Proposed research may be related to diseases, conditions, or symptoms supported by other CDMRP programs; however, TERP applications must be relevant to toxic exposures and be responsive to the FY22 TERP Program Goals and Topic Areas.
Who's Eligible
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:
Click on the following link to see the full text of the announcement for this funding opportunity.
Additional Information of Eligibility:
Unrestricted
Full Opportunity Web Address:
http://nspires.nasaprs.com/
Contact:
Agency Email Description:
CDMRP Help Desk
Agency Email:
Date Posted:
2022-09-21
Application Due Date:
Archive Date:
2022-12-31
Social Entrepreneurship
Spotlight
Building a Million Dollar Company Where Everyone Counts
Ganesh Natarajan is the Founder and Chairman of 5FWorld, a new platform for funding and developing start-ups, social enterprises and the skills eco-system in India. In the past two decades, he has built two of India’s high-growth software services companies – Aptech and Zensar – almost from scratch to global success.
Learn How to Identify and Avoid Grant Scams
